Nebraska Medicaid

Does Nebraska Medicaid cover Mounjaro?

Quick answer · Type 2 Diabetes

Nebraska Medicaid covers Mounjaro for type 2 diabetes with prior authorization on Medicaid.

  • Medicaid: Covered with requirements. A1C of 7% or higher

Last verified June 4, 2026. Policy effective June 1, 2026. Source: NE_PDL-20260601.pdf. How we verify this data →

Check your card for your exact plan →

Mounjaro for Type 2 Diabetes

What Nebraska Medicaid requires, by plan type. Open this indication on its own page →

Medicaid

Covered with requirements

What you need to qualify

  • A1C of 7% or higher
  • Diagnosis documented with a code
  • Trial of metformin for at least 90 days, or a documented reason it can't be used (["intolerance", "contraindication"])
  • Prior trial of 2 other GLP-1 medications (preferred GLP-1 RA agents (e.g., Ozempic, Trulicity, Victoza))
  • Lab results confirming eligibility

Qualification pathways

You can qualify through any one of these.

Non-Preferred Agent: Failed Two Preferred GLP-1 RAs

All of:

  • Failed trial of TWO preferred agents within GLP-1 RA class
  • Diagnosis of diabetes with HbA1C ≥ 7

Plus any one of:

  • Trial of metformin
  • Contraindication to metformin
  • Intolerance to metformin

Documentation to bring

  • Documentation of Type II diabetes diagnosis
  • HbA1C lab result ≥ 7
  • Documentation of trial and failure of TWO preferred GLP-1 RA agents
  • Documentation of metformin trial or contraindication/intolerance to metformin

Policy note: Mounjaro (tirzepatide) is listed as a non-preferred agent under the GLP-1 RA class on Nebraska Medicaid's PDL. Non-preferred agents require failure of TWO preferred GLP-1 RA agents, diabetes diagnosis with HbA1C ≥ 7, and metformin trial or contraindication/intolerance. The document notes 'AL' (age limit) and 'QL' (quantity limit) flags for Mounjaro, but specific thresholds are not detailed in this excerpt. The 'PEN' notation indicates this applies to the pen formulation.

Policy effective June 1, 2026 · verified June 4, 2026 · source: NE_PDL-20260601.pdf

Why Mounjaro requests get denied by Nebraska Medicaid

Based on what this policy asks for. Fix these before the first submission.

  1. Wrong brand for the diagnosis. Mounjaro and Zepbound are the same molecule with different approved uses; a request for Mounjaro under a diagnosis that matches Zepbound is routinely denied.
  2. Diagnosis code missing or wrong on the request.
  3. No recent A1C result on file.
  4. No documented metformin trial (dose, dates, and outcome) or a stated reason it can't be used.
  5. Required prior medication trials not documented.

Frequently asked questions

Does Nebraska Medicaid cover Mounjaro?
Nebraska Medicaid covers Mounjaro for type 2 diabetes with prior authorization on Medicaid.
Do you have to try metformin before Mounjaro?
Yes for type 2 diabetes: Nebraska Medicaid requires a documented trial of metformin of at least 90 days, or a documented reason it can't be used (["intolerance", "contraindication"]).
How current is this information?
This page reflects Nebraska Medicaid's written policy as of June 1, 2026, last verified against the source document on June 4, 2026.

Other medications under Nebraska Medicaid

Mounjaro coverage under other plans

All insurance plans · All medications

This page summarizes Nebraska Medicaid's written prior-authorization policy. It is not a guarantee of coverage; plans vary by employer and benefit design. Verify with your plan before relying on it.